D-0884-2017 Class II Terminated
FDA drug recall D-0884-2017 was initiated by Dr. Reddy's Laboratories, Inc. on May 22, 2017 and is designated Class II. Reason for recall: Failed Dissolution Specifications: out of specification results observed for low dissolution. The recall status is terminated (terminated Nov 19, 2018). Affected quantity: 89,118 cartons.
Recall details
- Product Type
- Drugs
- Report Date
- Jun 14, 2017
- Initiation Date
- May 22, 2017
- Termination Date
- Nov 19, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 89,118 cartons
Product description
Zenatane (isotretinoin) Capsules, USP, 20 mg, 30-count (3 x 10 Prescription Packs) per carton, Rx Only, Manufactured By: Cipla Limited, Kurkumbh Village, Pune 413802 India, Manufactured For: Dr. Reddy's Laboratories, Bachupally 500 090 India, NDC 55111-136-81
Reason for recall
Failed Dissolution Specifications: out of specification results observed for low dissolution.
Distribution pattern
Nationwide in the USA and Puerto Rico
Code information
Lot #: KB50361, KB50362, Exp 05/17; KB50540, Exp 07/17; KB50638, KB50639, Exp 08/17; KB50725, KB50726, KB50755, KB50756, Exp 09/17; 01KB60255, 79KB60252, 79KB60253, 79KB60254, Exp 03/18; 01KB60347, 01KB60348, 01KB60349, 01KB60350, 79KB60351, Exp 05/18; 01KB60421, 01KB60422, 01KB60423, 79KB60419, 79KB60420, Exp 06/18
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0884-2017
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026